GMK-REVISION FIXED TIBIAL INSERT SC SIZE 2/17MM
Report
- Report Number
- 3005180920-2024-00040
- Event Type
- Injury
- Date Received
- February 6, 2024
- Date of Event
- January 16, 2024
- Report Date
- February 6, 2024
- Manufacturer
- MEDACTA INTERNATIONAL SA
- Product Code
- JWH
- UDI-DI
- 07630030816833
- PMA / PMN Number
- K103170
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- 003
Narratives
BATCH REVIEW PERFORMED ON 06 FEBRUARY 2024: LOT 2008656: (B)(4) MANUFACTURED AND RELEASED ON 16-APR-2021. EXPIRATION DATE: 2025-09-02. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. ADDITIONAL DEVICE INVOLVED BATCH REVIEW PERFORMED ON 06 FEBRUARY 2024: GMK-REVISION 02.07.1202L FIXED TIBIAL TRAY CEMENTED SIZE 2 L (K090988) LOT 2002923: (B)(4) MANUFACTURED AND RELEASED ON 15-JULY-2020. EXPIRATION DATE: 2025-07-06. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, ALL ITEMS OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. SAME PATIENT OF MDR 3005180920-2022-00432. ETHNICITY AND RACE ADDED IN THIS MDR.
THE PATIENT HAD A PRIMARY KNEE SURGERY ON (B)(6) 2020. ON (B)(6) 2022, THE PATIENT CAME IN FOR A POST-OP APPOINTMENT WITH A LOOSE KNEE FEMUR AND OVERSTRETCHED MCL AND THE CAUSE IS UNKNOWN. THE SURGEON REVISED THE FEMUR AND ADDED SOME VARUS ALIGNMENT AND USED SEMI-CONSTRAINED FOR STABILITY. THE SURGERY WAS COMPLETED SUCCESSFULLY. ON (B)(6) 2024, THE PATIENT CAME IN REPORTING KNEE INSTABILITY AND THE CAUSE IS UNKNOWN. THE SURGEON UPSIZED THE INSERT, REVISED THE TIBIAL TRAY AND THE SURGERY WAS COMPLETED SUCCESSFULLY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 463275 | GMK-REVISION FIXED TIBIAL INSERT SC SIZE 2/17MM | KNEE TIBIAL INSERT | JWH | MEDACTA INTERNATIONAL SA | 02.07.0217SCF | 07630030816833 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Female | Required Intervention |